Inclusion complex of Rifampicin, an anti-tubercular drug, with beta-cyclodextrin or 2-hydroxypropyl beta-cyclodextrin and a process thereof
AssigneeCouncil of Scientific and Industrial Research
InventorsKakulapati Rama Rao, Nanduri Bhanumathi, Jhillu Singh Yadav, Neelam Srilakshmi Krishnaveni
Life of this patent
Estimating the term…
Abstract
The present invention relates to an inclusion complex of Rifampicin and cyclodextrin (CD) that can be used as an anti-tubercular drug. The present invention also relates to a process for synthesizing inclusion complexes of the anti-tubercular drug, Rifampicin, with β-CD (β-cyclodextrin) and HP-β-CD (2-hydroxy propyl cyclodextrin) and characterization of these inclusion complexes.
Claims10
An inclusion complex of Rifampicin and cyclodextrin.
An anti-tubercular drug comprising Rifampicin and cyclodextrin and a carrier.
A process for preparing inclusion complexes of Rifampicin and β-cyclodextrin, said process comprising adding Rifampicin to cyclodextrin and grinding in an agate mortar to form an uniform powdery material of Rifampicin-dextrin inclusion complex.
Dependencies are inferred from the claim text.